Stock 600789 SHANDONG LUKANG PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shandong Lukang Pharmaceutical Co.,Ltd.

Equities

600789

CNE000000P61

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 21/05/2024 am IST 		5-day change 1st Jan Change
8.92 CNY -3.98% Intraday chart for Shandong Lukang Pharmaceutical Co.,Ltd. -15.77% +24.93%
23/04 Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
22/03 Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Shandong Lukang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company's primary products include pharmaceutical preparation products, semi-synthetic antibiotic raw materials, veterinary antibiotics and antibiotic raw materials and others. The Company is also involved in the production and distribution of pharmaceutical intermediates. The Company distributes its products in domestic and overseas markets.

Number of employees: 6,484

Sales per Business

CNY in Million2022Weight2023Weight Delta
Veterinary Antibiotics
42.1 %
2,308 41.1 % 2,585 42.1 % +11.99%
Pharmaceutical Preparations
37.8 %
1,921 34.2 % 2,326 37.8 % +21.05%
Semi-synthetic Antibiotic API
11.3 %
785 14.0 % 693 11.3 % -11.65%
Other
4.3 %
275 4.9 % 264 4.3 % -3.98%
Antibiotic API
3.2 %
256 4.6 % 199 3.2 % -22.14%
Other Business
1.3 %
77 1.4 % 80 1.3 % +4.25%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
87.1 %
4,778 86.2 % 5,287 87.1 % +10.66%
International
12.9 %
767 13.8 % 780 12.9 % +1.72%

Managers

Managers TitleAgeSince
Kun Dong CEO
 Chief Executive Officer 55 19/21/19
Li Li DFI
 Director of Finance/CFO 58 01/16/01
Xin Peng CHM
 Chairman 51 01/94/01
Jie Zhang BRD
 Director/Board Member 57 01/03/01
Qiang Ming Bao IRC
 Investor Relations Contact - -
Li Xin Tian SEC
 Corporate Secretary 57 01/01/01

Members of the board

Members of the board TitleAgeSince
Hao Dong Qi BRD
 Director/Board Member 64 19/21/19
Zi Xin Deng BRD
 Director/Board Member 67 19/21/19
Xin Peng CHM
 Chairman 51 01/94/01
Li Li DFI
 Director of Finance/CFO 58 01/16/01
Jie Zhang BRD
 Director/Board Member 57 01/03/01
Ke Chun Cong BRD
 Director/Board Member 60 01/09/01
Cheng Tong Liu BRD
 Director/Board Member 53 01/14/01
Shuai Yang BRD
 Director/Board Member 50 18/13/18
Feng Liliang BRD
 Director/Board Member 56 19/21/19
Tao Zhang BRD
 Director/Board Member 37 11/21/11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 896,055,624 656,370,473 ( 73.25 %) 0 73.25 %

Shareholders

NameEquities%Valuation
Fullgoal Fund Management Co., Ltd.
0.5077 %
4,512,777 0.5077 % 4 M ¥
China Asset Management Co., Ltd.
0.1332 %
1,184,400 0.1332 % 1 M ¥
China Southern Asset Management Co., Ltd.
0.1165 %
1,035,330 0.1165 % 1 M ¥
Xin Peng
0.0648 %
576,200 0.0648 % 568 122 ¥
GF Fund Management Co., Ltd.
0.0540 %
480,000 0.0540 % 473 270 ¥
Wanjia Asset Management Co., Ltd.
0.0496 %
441,000 0.0496 % 434 817 ¥
Bosera Asset Management Co., Ltd.
0.0451 %
400,900 0.0451 % 395 279 ¥
Li Li
0.0353 %
313,800 0.0353 % 309 401 ¥
Wei Zhao
0.0345 %
306,700 0.0345 % 302 400 ¥
Kun Dong
0.0339 %
301,500 0.0339 % 297 273 ¥

Company contact information

Shandong Lukang Pharmaceutical Co., Ltd.

No. 88, Deyuan Road High-tech Zone

272000, Jining

+86 53 7298 5865

http://www.lkpc.com
address Shandong Lukang Pharmaceutical Co.,Ltd.(600789)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. Stock Shandong Lukang Pharmaceutical Co.,Ltd.
+24.93% 1.15B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 705B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.82% 583B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 332B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.64% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-4.13% 210B
NOVARTIS AG Stock Novartis AG
+10.63% 209B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600789 Stock
  4. Company Shandong Lukang Pharmaceutical Co.,Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW